In order of their dollar savings, these types of adverse events are where the AHA's HEN boasts its biggest savings:
- $166.3 million because 50,442 patients were prevented from requiring a readmission within 30 days.
- $15 million because 1,337 patients were prevented from acquiring a surgical site infection.
- $8.45 million because 611 patients did not develop a central line-associated bloodstream infection (CLABIS)
- $6.43 million because 368 patients did not have a ventilator-associated pneumonia.
- $3.13 million because 13,340 babies were not electively delivered without medical necessity before 39 weeks, resulting in 640 babies who did not require expensive hospitalization in a neonatal intensive care unit.
- $1.22 million because 2,806 patients did not develop a CAUTI.
- $933,400 because 96 patients did not develop a stage III or IV pressure ulcer
- $210,000 because 72 patients did not develop a post-operative pulmonary embolism or deep vein thrombosis (venous thromboembolisms or VTE).
The federal money provides support to build learning collaboratives, conduct training programs, technical assistance enabling hospitals to track and monitor improvement, and identify high-performing hospitals to serve as models for other hospitals trying to improve care.